SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
NCT00005931 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2005-06-24
Summary
The purpose of this study is to test the effectiveness of SU5416 in patients with AIDS-related Kaposi's sarcoma (KS).
Conditions
- Sarcoma, Kaposi
- HIV Infections
Interventions
- DRUG
-
SU5416
Sponsors & Collaborators
-
SUGEN
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma
NCT00002314 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002212 ·Status: COMPLETED ·Phase: PHASE2
-
SU5416 in Treating Patients With Malignant Mesothelioma
NCT00006014 ·Status: COMPLETED ·Phase: PHASE2
-
BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00024024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma
NCT00003419 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
NCT00000763 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
NCT00023725 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Selumetinib in Patients With Kaposi's Sarcoma
NCT01752569 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
NCT02029430 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
NCT00000681 ·Status: COMPLETED ·Phase: PHASE1
-
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
NCT00006361 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
NCT05411237 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
NCT00002445 ·Status: COMPLETED ·Phase: PHASE3
-
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
NCT04893018 ·Status: TERMINATED ·Phase: PHASE1
-
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
NCT00002259 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
NCT03157167 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002188 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00000996 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
NCT00000987 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
NCT00000660 ·Status: COMPLETED ·Phase: PHASE1
-
SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated
NCT00006003 ·Status: TERMINATED ·Phase: PHASE2
-
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
NCT01057121 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Anti-Retrovirals for Kaposi's Sarcoma
NCT00444379 ·Status: COMPLETED ·Phase: PHASE4
-
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
NCT00245102 ·Status: COMPLETED ·Phase: PHASE2